A Randomized, Active Controlled, Parallel Group, Multi-Center, Two Stage, Open Label, Study Comparing Safety and Immunogenicity of Insugen R and Insugen N with Actrapid and Insulatard in Patients with Type 1 Diabetes Mellitus.
Phase of Trial: Phase III
Latest Information Update: 05 Mar 2018
At a glance
- Drugs Insulin; Insulin suspension isophane
- Indications Type 1 diabetes mellitus
- Focus Therapeutic Use
- Sponsors Biocon
- 11 Jun 2010 Status changed from not yet recruiting to discontinued as reported by Clinical Trials Registry - India.
- 01 Jul 2009 New trial record